Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-07-27

Clinical Trial Update: Optimized Treatment and Regression of HBV-induced Compensated Liver Cirrhosis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating an optimized treatment for HBV-induced compensated liver cirrhosis has completed. The results suggest regression of liver cirr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Beijing Friendship Hospital | Conditions: Liver Cirrhosis | Phase 4 | Status: COMPLETED